Inspection readiness starts with a well-maintained TMF. A risk-based approach to oversight can help sponsors identify gaps early, reduce last-minute remediation, & build confidence ahead of regulatory inspection. Learn how to strengthen your TMF strategy: hubs.ly/Q04BXghX0

Unlike conventional psychiatric studies, psychedelic trials may center on a single, highly supervised treatment day. That changes what sites need to plan for before, during, and after dosing. Watch now: hubs.ly/Q04CfsyB0 #PremierResearch #Psychedelics #Neuroscience

Day 3 at #ESMO2026, and the momentum continues! Stop by Booth #8020 to meet our team and discuss the opportunities and challenges shaping the future of oncology research. hubs.ly/Q04CdX4N0 #PremierResearch #Oncology

Could a simple blood test help detect #BreastCancer as early as Stage I? A promising new test has entered clinical trials, offering the potential to improve early detection and expand opportunities for timely treatment. hubs.ly/Q04C0-df0 #PremierResearch #IndustryNews

What’s next in cancer immunotherapy? We’ll be at #SITC26 in Phoenix, where new science, translational research, and clinical insights will offer a look at where the field is headed—and what it could mean for oncology development: hubs.ly/Q04C7Rmv0 #PremierResearch

There’s no shortage of important conversations happening at #ESMO26. Our team is in Madrid exchanging perspectives on the realities of moving complex oncology programs forward. Visit us at Booth #8020 to join in on the conversations. hubs.ly/Q04C7VxC0 #PremierResearch

Women’s health has come a long way in clinical research, gaps in the data still shape cancer care today. Explore how thoughtful patient engagement & trial education can help advance more inclusive oncology research & the development of emerging therapies: hubs.ly/Q04BWV6B0

Heading to the 2026 NORD Rare Diseases & Orphan Products Breakthrough Summit? @Angi Robinson, @Paulla Dennis, and @Seth DePuy will be on site, bringing expertise across rare disease development, program strategy, and regulatory affairs. #PremierResearch #NORDSummit

What does readiness for FDA Accelerated Approval look like in rare disease development? Join Jackie Brown's session at WODC as she explores early strategies to reduce downstream risk and strengthen approval readiness. hubs.ly/Q04BD-Tw0 #PremierResearch #RareDisease

Accurate AE grading relies on timely, targeted oversight. From source data verification to medical review and site queries, our new infographic highlights ways to mitigate grading risk in early-phase #oncology trials. hubs.ly/Q04BDRvw0 #PremierResearch #AEManagement

Late-stage filing gaps can derail an otherwise strong development program. An earlier marketing application readiness assessment can help identify submission-critical risks across CMC, data, labeling, regulatory and more. Download our latest eBook: hubs.ly/Q04Blq1Z0

Our executive leadership is taking the stage at #CNSSummit2026! CEO John Ratliff and COO Siân Ratcliffe Smethurst will join four sessions spanning CRO leadership, clinical operations, and the evolving landscape of #CNS drug development. hubs.ly/Q04BLrzj0 #PremierResearch

Fresh ideas and plenty of practical conversations are happening at the Veeva R&D and Quality Summit in Boston. Our team is on site exploring what’s next across clinical operations, technology, quality, and the way development teams work. hubs.ly/Q04BNxZH0

Long #MDD maintenance studies can introduce risks around eligibility, retention, rater consistency and placebo response. How can sponsors stay ahead? This guide outlines practical strategies, from pre-enrollment review to risk-based monitoring: hubs.ly/Q04B0dJW0

Heading to #ESMO26 with questions about your #oncology development strategy, trial needs, or next steps? Meet with our team: hubs.ly/Q04BlnLZ0 #PremierResearch

At #OCTNewEngland, Alexandra Lyons will share real-world lessons from a complex oncology trial, including how stronger coordination helped accelerate start-up and kept enrollment moving. hubs.ly/Q04BlfPk0

Our team came together at Triangle Light The Night and Light The Night Connecticut to raise awareness and funds for blood cancer research. Thank you to everyone who joined us and who continue fighting for this important cause. #PremierResearch #LightTheNight